Welcome to the ISUP pre-meeting survey!
Predictive biomarker testing and companion diagnostics are increasingly part of daily genito-urinary pathology practise. At this moment, guidelines on specimen selection and requirements, immunohistochemical and molecular platforms, and standardised reporting are still lacking. At Saturday September 12, 2026, ISUP is organising a conference on precision marker testing in bladder and prostate cancer in Stockholm, Sweden, to resolve these issues.
In preparation of the conference, we want to get insight in current practise with respect to predictive biomarker testing around the globe. This will help to resolve common issues and identify gaps for future research. You participation in this pre-meeting survey is therefore very important and highly appreciated, even when you are not able to attend the conference itself in person.
The survey consists of 78 questions divided into 4 major sections:
In preparation of the conference, we want to get insight in current practise with respect to predictive biomarker testing around the globe. This will help to resolve common issues and identify gaps for future research. You participation in this pre-meeting survey is therefore very important and highly appreciated, even when you are not able to attend the conference itself in person.
The survey consists of 78 questions divided into 4 major sections:
1) Demographics (Question 1-3)
2) General attitude towards precision marker testing (Question 4-5)
3) Precision marker testing in bladder cancer (Question 6-37)
4) Precision marker testing in prostate cancer (Question 38-78)
Thank you for your time and participation!